The latest ASX shares to be hit with a broker downgrade

If you are looking for stocks to take profit on following the big rally, here are three that top brokers have just downgraded their recommendations on.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Risk appetite may be bouncing back recently with the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index chalking up more than 20% gains since January, but this isn't the time to get complacent.

If you are looking for stocks to take profit on following the big rally, here are three that top brokers have just downgraded their recommendations on.

One of the least favoured miners

One stock that got hit with a downgrade is the Fortescue Metals Group Limited (ASX: FMG) share price, which has slumped 3% in late afternoon trade to $8.72 after Morgan Stanley lowered its rating on the iron ore miner to "underweight" from "equal-weight".

"FMG is operationally a high-quality company. However, the stock is now ~13% higher than our price target," said the broker.

"We expect the headline iron ore price and 58% price realization to recede from current highs starting 1HCY20 as supply rises and Chinese mill profitability likely benefits from lower raw material prices."

Morgan Stanley has a $7.85 per share price target on Fortescue.

Not enough supplements

Meanwhile, the Clover Corporation Limited (ASX: CLV) share price has fallen out of favour with UBS. The broker dropped its recommendation on the stock to "neutral" from "buy" even after management posted a good full year result with earnings before interest and tax jumping by a third to $13.6 million.

"Growth was strong in all regions, before the impacts of European regulatory changes (likely in FY21E) and any potential changes in China (draft law published Sep-2018 but little information since)," said UBS.

"We continue to view the outlook as strongly favourable for CLV but following 98% share appreciation since Feb 2019, we believe most of the positive outlook (refer initiation report) is now largely factored into the share price."

Having said that, if Chinese regulators were to follow the Europeans and mandated DHA increases in infant formula, the broker will likely have to revisit its decision to downgrade the stock.

UBS has a 12-month price target of $2.75 a share on Clover.

Burning out

A downgrade by Bell Potter doesn't seem to have hurt the Avita Medical Ltd (ASX: AVH) share price with the stock trading 1.2% higher at 60 cents ahead of the market close.

The emerging biotech has received approval from the FDA to use its to conduct a pivotal trial of Recell in combination with meshed autografting for the treatment of trauma wounds.

"The inclusion of the trauma wound market as a label indication represents a vast new market for Avita, nevertheless the recent increase in market capitalisation to greater than $1.1bn indicates the value is already priced in," said Bell Potter.

"The model also assumes an increase in operating loss in FY20 to $19.8m largely as a result of increased operating costs and deferral of revenues from the BARDA procurement. Valuation is amended from $0.68 to $0.69. Our recommendation is reduced to Speculative Hold."

Brendon Lau has no position in any of the stocks mentioned. Connect with him on Twitter @brenlau.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Clover Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why 29Metals, Brainchip, Platinum, and Premier Investments shares are falling today

These ASX shares are having a tough time on hump day.

Read more »

Man with his head in his head because of falling share price.
Share Fallers

Why 29Metals, Atlas Arteria, IDP Education, and Mineral Resources shares are falling

These ASX shares are having a tough time on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ALS, EOS, NRW, and Patriot Battery Metals are dropping today

These ASX shares are starting the week in the red.

Read more »

A man looking at his laptop and thinking.
Technology Shares

Why are these ASX tech shares getting smashed today?

Owners of these two stocks are missing out today.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why AGL, Brickworks, IGO, and New Hope shares are dropping today

These ASX shares are having a poor session. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Amcor, Arafura, Brainchip, and South32 shares are tumbling today

These ASX shares are having a tough time on hump day. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Aussie Broadband, Liontown, Metals Acquisition, and Seek shares are falling

These ASX shares are having a poor session. But why?

Read more »